Financials Lipidor AB

Equities

LIPI

SE0012558617

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:18:41 2024-04-29 am EDT 5-day change 1st Jan Change
0.25 SEK +6.38% Intraday chart for Lipidor AB +6.38% -50.40%

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 388.2 355.9 248.8 21.33
Enterprise Value (EV) 1 361.1 291.6 197.5 12.4
P/E ratio -24.1 x -20.4 x -11.1 x -0.52 x
Yield - - - -
Capitalization / Revenue 521 x 571 x 16 x 73 x
EV / Revenue 485 x 468 x 12.7 x 42.5 x
EV / EBITDA -26.2 x -18 x -9.28 x -0.3 x
EV / FCF 65,515,346 x -30,539,026 x -31,696,511 x -516,671 x
FCF Yield 0% -0% -0% -0%
Price to Book 14.5 x 6.02 x 5.53 x 9.94 x
Nbr of stocks (in thousands) 23,584 26,384 29,977 28,977
Reference price 2 16.46 13.49 8.300 0.7360
Announcement Date 5/12/20 4/23/21 4/28/22 4/26/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.3296 0.243 0.745 0.623 15.6 0.292
EBITDA 1 -2.207 -7.599 -13.79 -16.22 -21.27 -41.2
EBIT 1 -2.627 -7.634 -13.81 -16.26 -21.38 -41.47
Operating Margin -797.03% -3,141.56% -1,853.42% -2,610.59% -137.09% -14,202.05%
Earnings before Tax (EBT) 1 -2.627 -7.637 -13.81 -16.2 -21.29 -41.38
Net income 1 -2.627 -7.637 -13.81 -16.2 -21.29 -41.38
Net margin -797.04% -3,142.8% -1,853.29% -2,600.96% -136.49% -14,170.89%
EPS - -0.5100 -0.6832 -0.6600 -0.7482 -1.428
Free Cash Flow - -15.13 5.511 -9.549 -6.231 -24
FCF margin - -6,225.57% 739.78% -1,532.74% -39.94% -8,219.09%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/30/18 5/29/19 5/12/20 4/23/21 4/28/22 4/26/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 0.56 1.17 27.1 64.3 51.3 8.93
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -15.1 5.51 -9.55 -6.23 -24
ROE (net income / shareholders' equity) -75.6% -85.2% -66.9% -35.8% -39.7% -181%
ROA (Net income/ Total Assets) -33.7% -41.9% -37.1% -21.6% -22.1% -73.4%
Assets 1 7.794 18.22 37.18 75.06 96.3 56.39
Book Value Per Share - 0.9600 1.140 2.240 1.500 0.0700
Cash Flow per Share - 0.0800 1.150 2.260 1.770 0.3100
Capex - - - 0.32 0.77 0.46
Capex / Sales - - - 50.72% 4.96% 157.19%
Announcement Date 5/30/18 5/29/19 5/12/20 4/23/21 4/28/22 4/26/23
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise